Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Szekesfehervar – page 3

161 clinical trials in Szekesfehervar, Hungary across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Szekesfehervar at a glance
161
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

161 trials in Szekesfehervar

Open in trial search

Obesity

Recruiting

RO7795068 for Weight Loss in Adults With Obesity or Overweight Without Type 2 Diabetes

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Sponsor:F. Hoffmann-La Roche AG

A study to evaluate the effectiveness and safety of AZD1163 in adults with moderate to severe rheumatoid arthritis

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:AZD1163
  • Sponsor:AstraZeneca AB

Comparing sotorasib and pembrolizumab with chemotherapy for patients with advanced non-small cell lung cancer and a KRAS G12C mutation

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Amgen Inc.

A study to evaluate the effectiveness of tenecteplase in patients with acute ischemic stroke who are more than 4.5 hours after their last known well time.

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Tenecteplase
  • Sponsor:Boehringer Ingelheim International GmbH

A study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Sponsor:Eli Lilly & Co.

Evaluation of Long-Term Safety and Efficacy of Litifilimab in Adults with Active Systemic Lupus Erythematosus: A Phase 3 Multicenter, Randomized, Dose-Blind Study

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Litifilimab
  • Sponsor:Biogen Idec Research Limited

Hidradenitis

Recruiting

A Study of Brivekimig Compared to Placebo in Patients with Moderate to Severe Hidradenitis Suppurativa

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Study comparing GSK5764227 and topotecan in adults with relapsed small cell lung cancer

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:GSK5764227
  • Sponsor:Glaxosmithkline Research & Development Limited

Study of SAR444336 in Adults with Microscopic Colitis Who Achieved Clinical Remission with Budesonide Treatment

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:SAR444336
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Study on Lutikizumab and Risankizumab for Adults with Active Psoriatic Arthritis

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Lutikizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Study of Sigvotatug Vedotin and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with High PD-L1 Levels

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Pfizer Inc.

Anaemia+1

Recruiting

Study of Elritercept for Treating Anemia in Adults with Low to Intermediate Risk Myelodysplastic Syndromes

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Elritercept
  • Sponsor:Takeda Development Center Americas Inc.

Other cities in Hungary

The busiest research cities in the country

All 71 cities in Hungary

Clinical research in Szekesfehervar

What the registry says about research in the country

01 Rheumatology and Autoimmune Conditions

Innovative clinical research focusing on psoriatic arthritis, rheumatoid arthritis, and Sjögren's Disease. Studies are evaluating new therapeutic approaches for patients with varying treatment histories.

  • Multiple psoriatic arthritis treatments
  • Novel antibody therapies
  • Autoimmune disease interventions

Research includes investigations of biologics and targeted therapies for patients with inadequate response to conventional treatments.

02 Cardiovascular and Metabolic Disorders

Studies targeting heart failure prevention, cardiovascular disease, and complications of Type 2 Diabetes. Research focuses on innovative therapeutic combinations and preventive strategies.

  • Heart failure risk reduction
  • Cardiovascular outcomes
  • Diabetes management

Trials are investigating novel drug combinations and their impact on major cardiovascular events.

03 Respiratory and Oncology

Advanced research in non-small cell lung cancer and pediatric asthma. Studies are evaluating targeted therapies and innovative treatment approaches.

  • Lung cancer treatments
  • Pediatric respiratory care
  • Post-surgical interventions

Clinical investigations include both early-stage cancer treatments and management of chronic respiratory conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.